Abacus Global Management, Inc. (ABX) Earnings Call Transcript & Summary
August 6, 2026
Earnings Call Speaker Segments
David Jackson
executiveThanks, operator, and I appreciate all of you taking the time to be on Abacus Global Management's second quarter earnings call. Joining me on this call are Jay Jackson, our Chairman and Chief Executive Officer; Elena Plesco, our Chief Investment Officer; and Bill McCauley, our Chief Financial and Chief Operating Officer. At 4:15 p.m. Eastern Time this afternoon, Abacus Global Management put out our results for the second quarter of 2026. On today's call, participants will have the chance to pose questions regarding those results. Before we get started, Abacus Global Management directs those listening to the investor web page, ir.abacusgm.com, where the press release, investor information and filings with the SEC can be found, for a discussion of risks that may impact the business. Abacus Global Management points listeners more specifically to the presentation furnished today on Form 8-K with the Securities and Exchange Commission, and cautions those listening that certain comments made today might include forward-looking statements and, as such, will be subject to risks and uncertainties that, should they come to pass, could materially affect results. For additional detail on the risks, uncertainties and assumptions tied to forward-looking statements, please see Abacus Global Management's public filings. On this call, we will mention certain non-GAAP financial measures. While we believe these measures offer useful supplemental information regarding our financial performance, they are not recognized measures and lack standardized meanings under U.S. generally accepted accounting principles, or GAAP. Please consult our public filings for further information about our non-GAAP financial measures, including references to comparable GAAP measures; with that, I would now like to hand the call over to Jay Jackson, Abacus Global Management's Chairman and Chief Executive Officer.
Jay Jackson
executiveThanks, David, and I appreciate all of you taking the time to be with us. It was great to see such a strong turnout in person at the NYSE last month for our Investor Day, where we laid out our vision for Abacus Global Management. We'd ask everyone to check out the replay that's posted on our IR website. If you couldn't attend, the message we delivered at Investor Day was simple. We hold a strong conviction that personalized longevity data will transform and upgrade traditional asset management. Even more than that, we're confident Abacus holds a one-of-a-kind position as the top data and technology platform that makes this transformation possible. Let me begin with a figure that's redefining our whole industry: $124 trillion. That's the amount that will move from baby boomers to their children and grandchildren across the coming 3 decades — the biggest wealth transfer ever recorded — and virtually all of it is being planned right now based on a guess. Each financial plan takes a position on a single question: how long must the money last? Yet hardly any of them truly have an answer. On the most critical input of all, they simply grab a population average — but no one is actually average. What we can do is swap that guess for a personalized lifespan, and that's precisely the role LifeARC plays, converting a person's medical, genetic, medication and biometric data into a portfolio designed around the life they truly live. We can do this because we carry a 20-year head start grounded in exactly that data, which puts Abacus in position to serve as the intelligence layer for lifespan linked finance. The simplest way to explain it is through a company you all know. Amazon created AWS to power its own marketplace, and it grew into one of its most significant profit engines. Our origination platform functions as our commerce engine, while LifeARC is our AWS. That growth is already visible in our results. During the first half of 2026, we brought in $544.2 million of inflows into our longevity funds, beating our $500 million target for the period and compared with roughly $604 million for the entirety of 2025. On a separate note, we're only in the earliest stages of deploying LifeARC for others, and that's where the wealth transfer opportunity becomes real. Through our partnership with Manning & Napier, their advisers will be able to apply personalized lifespan modeling across the $18 billion they manage for 3,400 clients. Manning & Napier isn't some outlier. It's the playbook — and that playbook points toward something larger. So when we describe Abacus, we're not a traditional asset manager. What we're building is the infrastructure for lifespan-linked finance. Our mission is to control the data, products and distribution rails that empower advisers to construct portfolios around each individual's particular lifespan drivers — so the next generation can invest that $124 trillion around real lifespans instead of generic averages. That's the opportunity we're working toward. And this quarter provided genuine evidence that we're on the right track. Bill will walk you through the quarter's details shortly, but first I'd like to highlight 2 things I'm particularly thrilled about. To start, we got SEC effectiveness for the ABX Longevity Growth and Income Fund, ticker ABXGX, and launched it. This is our inaugural registered interval fund focused on the longevity asset class; for the first time ever, individual investors along with their advisers are able to reach this asset class via a registered vehicle, and it represents a direct fulfillment of the strategy we presented at Investor Day. Next, extending that very same push to unlock the asset class is asset tokenization. Let me be straightforward regarding what this is and what it isn't; when it comes to Abacus, this isn't a crypto strategy. It's financial infrastructure. We're creating an immutable on-chain record for every policy's chain of title, liens and cash flow rights, which renders the secondary life insurance market more transparent, more transferable and more investable. This market has traditionally been opaque and difficult to transact in, and placing it on chain starts to alter that. We've begun tokenizing in-force policies already, and we view this as infrastructure that leverages the strength of our origination platform as we keep growing our recurring fee-based revenue; those milestones demonstrate the sort of progress we're achieving. Shifting to the nearer term, we feel quite good regarding the business's trajectory as we move through the rest of the year. Together with our results, we're offering guidance for the third quarter. The momentum we established during the first half across our origination platform and disciplined monetization gives us genuine confidence in where we're headed. With that, I'll hand it over to Bill to take you through the quarter in detail.
Bill McCauley
executiveThanks, Jay. To kick things off today, I want to take you through how our origination platform, fund management, profitability, and the continued scaling of our operating cash flow delivered a strong operating performance this quarter. Then I'll share our outlook for 2026 from here, including what we anticipate for the third quarter, and finish with a status report on the Manning & Napier integration. To start, as Jay noted, Abacus maintained the momentum it built in the first quarter, putting roughly $200 million of capital to work during Q2, bringing total capital deployed so far this year to $362 million. Even as we held to our disciplined approach, the number of policies under review continued to climb across our platform. In the second quarter, we managed to examine 9,314 qualified policies, compared with 8,786 such policies during the first quarter. Year-to-date, the total number of policies we've looked at, qualified plus non-qualified, went past 50,000 — a milestone we hit by growing top-of-the-funnel leads and speeding up the time it takes to review each case using artificial intelligence. Looking ahead to the latter half of 2026, we anticipate that inbound policies under review will continue to increase as we deepen penetration and make greater use of distribution channels, including Manning & Napier. Let me now walk through the quarter's financial results. Revenue at Abacus rose 30% versus last year, reaching $73 million. Growth was led by Life Solutions, which climbed 38.3% year-over-year to $65.4 million. This expansion was partly counterbalanced by reduced fees from asset management, largely driven by a drop in AUM within our ETF strategies stemming from market conditions as well as outflows. Those decreases were offset by strong inflows into our longevity funds, which reached $256 million during the quarter. As Jay mentioned, we continue to perceive considerable opportunity to leverage the strength of LifeARC, and we remain confident that revenue from both asset management and technology service fees will make up an increasing share of our revenue base moving forward. Relatedly, technology service fees have climbed to nearly $1 million year-to-date, which aligns with the ongoing build-out and adoption of that business. Now shifting to expenses. Operating expense in total was $42.5 million for the quarter. The main reason for the rise compared with last year is higher spending on strategic business initiatives and other personnel-related costs tied to acquisitions and expansion, since we're building out the asset management, wealth management and technology portions of the platform. Turning to profitability: adjusted net income, which strips out noncash stock compensation along with non-recurring expenses connected to business acquisitions and special projects, came to $27.1 million, or $0.28 per diluted share. We're glad to report that both figures beat the Q2 guidance we gave in May, which called for $24 million to $26 million in adjusted net income and $0.24 to $0.26 in adjusted EPS. To restate that point, Abacus remains dedicated to responsible growth that preserves operating margins and cushions consolidated profitability. Turning to our adjusted EBITDA, we had a strong second quarter, bringing in $40 million — that's up 27% from the same period a year ago. The adjusted EBITDA margin came in at a healthy 55% for the quarter. Overall, we're very pleased with how strongly our platform has continued to expand, and that factors in the investments we're making to fuel future growth. In Q2, we delivered another stretch of excellent performance: revenue grew 30%, EBITDA was up 27%, and margins stayed consistent. Moving now to the balance sheet — on an adjusted basis, return on equity reached 25%, which represents a 400 basis point improvement over the prior year's level. When the quarter closed, we held $23.4 million in cash, and policy assets added up to $383 million. Setting aside any nonrecourse liabilities, our long-term debt sits at $290.8 million. Looking ahead to Q3, our projection is adjusted net income between $26 million and $28 million, alongside adjusted EPS ranging from $0.26 to $0.28 per share. As for the entire year, after raising our guidance last quarter, we're reaffirming that we anticipate adjusted net income between $100 million and $106 million, with adjusted EPS of $1 to $1.05 per share. Zooming out, we're optimistic about where the business is headed as we progress through the back half of the year. That optimism rests on how strong our origination platform is, our careful approach to monetization, and the ongoing expansion of our fee-based and technology-driven revenue streams. I'd also like to address one administrative point regarding the way we present guidance. We give our adjusted net income guidance on a gross basis, which means adjustments get applied prior to accounting for taxes, matching both our historical practice and the approach our covering analyst uses in their models. To minimize any potential misunderstanding, we're now also sharing the tax-affected, or net, equivalents. To begin, in our Q1 10-Q we introduced a schedule reconciling gross adjusted net income and EPS down to their net equivalents, and you'll find that same reconciliation again in the Q2 10-Q. The tax rate used to move from the gross add-back items to the net figures comes in at roughly 25%. Other than the tax impact, the gross and net numbers rest on identical assumptions. Looking ahead, our plan is to move toward providing guidance on a net basis, and by giving you both figures today, we're trying to make that transition as seamless as possible. Last, I want to call out a few early wins coming out of the operational integration with Manning & Napier. Since the investment closed in May, we've set up a live referral channel connecting the 2 firms, and we're turning Abacus' own unqualified leads into wealth management clients for Manning & Napier, guiding individuals who originally came to us for a single need into a comprehensive advisory relationship. Simultaneously, we're digging into the policies on their side and reviewing their books of business to pinpoint qualified policies eligible for settlement, uncovering value that had been lying dormant within their current client base. And as the foundation for all of this, we've started deploying LifeARC throughout their adviser network, delivering personalized lifespan modeling straight to the people who meet face-to-face with those clients daily. When you put all of this together, what we're seeing are precisely the initial validation markers we were looking for, and they provide us with genuine confidence regarding how this approach carries over into the upcoming quarter. So, with that said, I'll now hand things over to Elena, who will walk through how our balance sheet and investment strategy performed.
Elena Plesco
executiveThanks, Bill. There are three items I'd like to address on this call: first, a review of how our balance sheet did; second, a discussion of what we've constructed on the asset management front and the way we financed it; and third, some perspective on our numbers relative to developments across the wider alternatives sector. The reason is that the sharp difference we saw this quarter forms a major part of the narrative. Starting with the balance sheet: in Q2, portfolio turnover on an annualized basis came in at 2x, sitting at the upper bound of the 1.5 to 2x range we target over the long run. Turnover at that pace demonstrates that demand remains steady for the assets we originate, and it shows we can recycle capital efficiently while maintaining our underwriting standards. Roughly $197.9 million of capital was put to work in the quarter, a 62% increase versus the same period a year earlier, which signals that both origination volume and investor appetite are robust. On policy sales, our average realized gain came in at about 25%, well ahead of the 20% plus long-term target we've set. I'd like to emphasize what that figure actually means, since it sits at the heart of our view of this business. Our book turns over about two times per year, so these aren't paper marks on a screen. These are completed transactions at actual prices with actual counterparties. Each time the book turns, it confirms the fair value we carry. With the market currently devoting enormous effort to arguing over whether private asset marks can be trusted, that difference is significant. I'll return to this point. One gauge of balance sheet efficiency that deserves mention is holding period. The policies we sold during the quarter had been held for an average of about 230 days, compared with about 153 days for policies that remain on the balance sheet. That gap of 77 days demonstrates that we're converting more seasoned positions into cash while letting newer, high conviction assets continue working for us as they season. Now to asset management, since that's where the strategy made real progress this quarter. The big news is the launch of the ABX Longevity Growth and Income Fund, which won SEC effectiveness just after the quarter closed. It is the first registered interval fund focused on the longevity asset class, and it gives individual investors and their advisers access to our strategies for the first time. That represents a structural broadening of who can reach this asset class — not merely one more product. On fundraising, our longevity funds brought in $544.2 million collectively during the first half of the year, exceeding the $500 million goal we'd set for that period. Net inflows to those funds during the second quarter by themselves totaled approximately $256.1 million, while management and servicing fees for the longevity funds came to $6.5 million in the quarter. Fee-paying AUM platform-wide now stands at about $3.2 billion, with total AUM at $3.5 billion. It's useful to step back and consider how the two sides of the house perform, since we manage capital in two places and they operate off a single engine. The balance sheet is where assets get originated. These funds operate as separate vehicles, yet they rely on one origination platform, one set of underwriting standards, and one servicing operation, all built to deliver recurring distributions alongside long-dated capital appreciation. That's the entire premise of the model, and it's the evidence that the flywheel functions. Our balance sheet shows in cash terms that these assets behave the way they were underwritten to behave. Through the funds, outside investors get to take part in that at scale. As fee-paying AUM expands, management fee revenue expands too, without a matching rise in balance sheet capital, and that lifts both returns and capital efficiency as time goes on. Fee-related revenue currently sits in the teens as a share of our mix, and we're aiming for 70% by 2030. Now let me place all of this within the broader market, since I believe it explains why our results came out as they did. Right now, the headline narrative across alternatives is private credit, and more specifically, the strain it faces. Across the past 2 quarters, we've witnessed sizable redemption activity in non-traded credit vehicles, fundraising decelerating in portions of that market, and rating agencies publicly monitoring liquidity cushions at credit-focused funds. Non-listed BDC sales dropped significantly during the first quarter. The conversation has moved away from how quickly private credit might expand toward whether the marks can be trusted and whether liquidity terms survive pressure. Many of the big managers have made the fair case that this stress is idiosyncratic, not systemic. My aim isn't to downplay that. What I want to highlight is why it's mostly not an issue for us. Corporate credit isn't what our assets are. What drives their performance is mortality, not interest rates, spreads, borrower profitability, or the economic cycle. That's what an uncorrelated return means, and it's precisely what institutional allocators claim to seek when they diversify away from overcrowded corporate credit exposure. When the market worries about whether an asset can be sold at its carried value, our book turns over twice per year and gives us the answer in cash; and when the worry is liquidity mismatch, our interval fund was purpose-built to match investor liquidity with the underlying assets instead of promising daily liquidity against illiquid holdings. So the very environment causing stress elsewhere serves, for us, as a demonstration of why this asset class exists: uncorrelated, cash validated, and structurally matched. That's the pitch. And this quarter, the results backed it up. Zooming out, the story stays simple; we operate a differentiated origination platform, backed by disciplined underwriting and consistent monetization. And on top of it, we're scaling an asset management platform built to produce a growing base of fee-related earnings. Those priorities match exactly what we set out at Investor Day, and the second quarter represented genuine progress along that road map. With that, I'll hand it back to Jay for some closing thoughts.
Jay Jackson
executiveAppreciate that, Elena. Prior to opening things up for your questions, there's one key point I want to stress for our investors and analysts. You can plainly sense how thrilled and assured we are about the way Abacus is going to transform the asset management sector. As I've said before, what lies ahead of us is a generational-sized opportunity, and we're confident that Abacus' platform, driven by LifeARC, will seize a growing portion of the value that our data provides to asset managers along with their investors. So I'll close with this: you've previously heard me discuss our stock price and market cap. Let me also say that we're confident Abacus will grow far bigger on the strength of our existing business lines by themselves. And the greatest part is that we enjoy substantial visibility into that expansion. That's the main factor behind our continued buybacks of our shares. We're eager to execute and unlock the full opportunity for our shareholders. With that, I'll hand things back to the operator for your questions.
Patrick Davitt
analystMy first question concerns the outlook. You just exceeded the upper bound of your forecast range for 2Q, surpassed consensus by a wide margin, and are now steering toward a figure higher than consensus for 3Q, yet the annual guidance stays at $1 to 105. Viewed that way, does anything in the pipeline point to a weaker 4Q for some reason? Or is this simply a matter of remaining cautious?
Jay Jackson
executiveYes. Thanks for asking, Patrick; we were simply being cautious with the yearly guide. We're aiming toward the upper bound of that guidance, which would leave us in a very strong spot for Q4. When we were setting our guidance, we preferred to keep it nearer to the short term in Q3; and then when we examined Q4, we were aiming more toward the upper bound of that guidance. So plenty of growth lies ahead of us. And I believe that showed in Q2 and, naturally, with the raise in Q3, and we anticipate seeing the same kind of results that we'd have in Q4, which would place us at the upper bound of the annual.
Patrick Davitt
analystAll right, that's reasonable. My next question concerns the interval fund — it's at last been rolled out, which was terrific to witness. Therefore, I'd like to hear your refreshed perspective regarding initial adoption by the advisers with whom you already have tight relationships, whether through Dynasty or Manning. Also, how much of a pipeline exists for additional distribution platforms that will come aboard down the road and with which you're currently holding talks?
Jay Jackson
executiveIndeed. There is nothing else like the Interval Fund; navigating the SEC's process consumed a considerable stretch of time, yet having the product we now offer in the market makes us immensely proud. We are collaborating very closely alongside custodians. Our Board meetings have taken place, and we have spoken with quite a few very big distribution firms, meaning RIA outfits. Dynasty and Manning, along with others, definitely sat at the top of our list, yet we additionally have companies beyond those ties that have been eagerly, enthusiastically waiting for this product to arrive. Essentially, it is a yielding product with no correlation at a moment when, in my view, investors broadly are hunting for assets of that uncorrelated type. What makes the interval fund so good is that retail investors aren't its only audience. We have been presenting it to every one of our pension fund clients with whom we already do business, particularly via our mortality verification work. That has sparked a considerable degree of interest as well. So it isn't only RIAs — institutionally, we're witnessing this draw plenty of notice. We anticipate bringing in assets during Q3. And Q4, without a doubt, should prove to be a really strong quarter for fresh assets flowing into the interval fund.
Crispin Love
analystTo start with, the amount of capital put to work was really robust — I think it came close to $200 million during the quarter. Could you walk through a few of the factors behind that deployment this quarter? And then what should we expect in the near term? My recollection is that you previously mentioned a range of $130 million to $150 million. Is that still the right way to think about it? Or might we see some quarters running higher, like the one we just had?
Jay Jackson
executiveCertainly. Thanks, Crispin. Looking at Q2, our approach is always to align the capital we deploy and the originations we generate with fresh capital coming in. We posted yet another record Q2 for new capital entering the longevity funds; because of that, we wanted to ensure those dollars got put to work, and there was no shortage of opportunity. Something we keep discovering is that demand for the underlying asset remains in excess of supply. I'd also point out that we've discussed this quite a bit over the past several quarters, specifically regarding a securitization. We believe we're advancing further along in that process. Should we manage to proceed with the securitization in Q3, or perhaps even early Q4 — though Q3 is the target, as we mentioned on the previous call — then in my view we could quite comfortably watch that capital deployed figure rise beyond our original objective of $130 million of $150 million, landing in the $150 million to $175 million range. That said, Q3 has historically shown a bit of seasonality when it comes to capital deployed and acquisitions, with a stronger ramp in Q4. So we feel we're sitting in a very good position. My expectation is that those figures will climb from what we had been projecting — $130 million to $150 million — to something nearer $150 million to $175 million. Q2 was outstanding for us. What I want to emphasize is that this works when we have capital that lines up with demand, and we definitely have both the origination and the inventory to support that. So it's a very, very persuasive picture, and it carries us into what I expect will turn out to be a fairly robust year.
Crispin Love
analystExcellent. And at Investor Day, plus on this call as well, there was plenty of discussion regarding LifeARC. The platform is fresh, I realize, but could you provide the most recent update, beyond internal use and the work with Manning & Napier? My guess is that financial advisers and insurers represent the main customer base for this offering. Have sales begun at this point? I'm also wondering what the revenue structure might eventually be. My assumption is a subscription-style expense, though any detail on pricing goals would be useful.
Jay Jackson
executiveThanks. LifeARC is an initiative we've devoted effort to across multiple years, and it is picking up considerable momentum. In fact, this week we appeared on Fox Business Mornings with Maria to discuss that initiative, and the reaction from people eager to run through it using an online calculator available at abacuslifearc.com was fairly remarkable. What we've discovered is that a substantial volume of direct inquiries has come in, and we've been able to bring Manning on board in real time. We've likewise seen considerable interest from sizable RIA firms nationwide that want to make use of this platform. Consequently, our intended method of generating money from the platform leans toward a revenue-sharing arrangement rather than a per-life approach. Along those lines, we're currently negotiating with certain firms regarding how such a rev share structure would be set up. That said, our main priority for LifeARC is getting it deployed inside the Manning & Napier platform, and we're achieving considerable success on that front. What we're seeing is that these aren't merely, as one might expect, smaller accounts—we're discussing accounts worth multiple millions of dollars, where clients genuinely wish to grasp this data more thoroughly, since the outcomes are boosting the income they draw throughout retirement along with what they pass on as a legacy. I've discussed this frequently, but this represents a $124 trillion market for generational wealth transfer. And what it's genuinely producing is dialogue with the following generation. So keep watching—there's more ahead. This is truly occurring and advancing extremely rapidly. We've gotten a substantial volume of interest from very large firms, and the approach we're considering for pricing this would be a recurring revenue structure within a rev share.
Crispin Love
analystGreat. Did Treasury Secretary Bessent reach out?
Jay Jackson
executiveThat's a great question. Right now, I'm not sure whether I'm able to discuss any potential contacts; however, I can say that we've been communicating with multiple government agencies regarding our work involving LifeARC and mortality verification. And I believe it's only a matter of time until that program gets rolled out. Let me mention just one thing. Hopefully, you saw this in the deck — we moved from 4 million lives tracked to more than 6 million quarter-over-quarter. I mean, that's just an enormous quarter-over-quarter jump coming from pension funds, insurance companies, et cetera. So that program is truly building momentum.
Andrew Kligerman
analystThat slide is quite interesting, with average realized gains hitting 25% for the quarter. It got me wondering how we should think about that figure. I mean, it's reached 37% at the high end and dropped to 21% at the low end. The other part of my question concerns the market landscape and appetite for your policies, which appears quite strong. Then, looking at the other side, there's the rivalry involved in purchasing policies. So perhaps you could address those elements and, in the end, what types of gains we should use as a benchmark.
Jay Jackson
executiveAbsolutely. Regarding ROE realized gains — that figure being gross realized gains — I believe we experienced an unusual Q3 in the prior year at 37%, and I think we pointed that out. Historically speaking, we've generally stayed within a 20% up to 25% top-end band. We see no reason for that to shift in the near term. I think we've built a very lengthy record of how those realized gains tend to appear. Looking ahead to Q3 and Q4, one factor affecting that as we progress into '27 that I'd note is what will sustain those realized gains and perhaps even grow them as our cost of capital keeps declining; and this connects to your other point, Andrew — a few things can influence that. Should we achieve greater success in securitizations or other formats with lower cost of capital, then yes, you might observe that realized gain potentially rise somewhat. We could then revisit what our historical average has been, yet we're still upholding that historical average; and I think the fascinating part is that this links to supply. As we potentially face heightened competition spurring interest in acquiring the contracts, I think what this ultimately boils down to is that we stand as the sole publicly traded entity in our whole sector. We're a major national institutional firm possessing extensive reach. So what we're truly discussing is the size of the addressable market. Consider this — we've discussed it before — $14 trillion of individual life insurance in force, 90% of which typically lapses. If you simply divide that into what we believe our addressable market to be from the $14 trillion annually, each year, roughly $250 billion. I think our industry is hardly reaching 1.5% of that. So even should you encounter some extra competition entering, we're simply nowhere close to the scarcity of supply we might encounter. It's merely about then putting in investment, growing your resources, and persistently enlarging your origination footprint. Also, I'm not really worried about rivals entering the space, since there are still so many policies that every one of us needs to win and bring on board. So this higher level of demand exists, and it will remain, just as it has for other players — we've essentially turned into an alternative to certain private credit choices, and right now people are searching for and pursuing uncorrelated or less correlated yielding products more than they ever have before. And Abacus sits in a fantastic position to deliver those products, to deliver those investments for people to put money into and take part in. And we've got the supply to meet that demand. So we're simply in a truly strong place, and that will keep going not merely for a handful of quarters, but across the coming several years.
Andrew Kligerman
analystThat's really appealing. With Manning & Napier, it still feels like we're in the very early stages, correct, since that transaction closed in May of '26, so the growth path seems to be building. Yet based on what you said in your prepared remarks, you come across as quite enthusiastic. You also mentioned partnerships a bit. But is it better to acquire equity positions such as the one you took in Manning & Napier rather than simply arranging a pure revenue share, which you brought up? And given that, do more companies like Manning & Napier exist?
Jay Jackson
executiveYes. Manning & Napier is an excellent organization, and our opinion of them is extremely high. Over the past few months we've been completing integrations for our strategic alliance, and that has turned out to be a success and is expanding. Prior to examining additional companies, we wanted to make sure the money we've put into this one will produce revenue, that the synergies we've described are real, and that we can grow it and afterward duplicate it in other parts of the country. What we've discovered, at least at this early point, is that every one of those things is accurate. We're tremendously enthusiastic about Manning & Napier as an organization, as a business. The people there are amazing. That's the kind of company we believe we can even contribute a great deal to in terms of growth through Legion, LifeARC and investment products. So it follows logically that as we survey the country, yes, there are further possibilities where, if we can locate comparable synergies, I believe the effect on the RIA industry overall will be enormous. However, when we consider our distribution channel and the way we keep distributing our own products and sourcing policies, those Manning & Napier firms, and ones similar to them, are extremely attractive.
Timothy D'Agostino
analystRegarding the route to more than $5 billion in AUM by the close of '26, I suppose, might you assist in connecting where we stand now with reaching that objective? And is a considerable portion of that arriving via the longevity fund?
Jay Jackson
executiveCertainly. Thanks. Reasonable question; and yes, it's arriving via longevity funds. It's likewise arriving via, as we've discussed, certain new products. The interval fund will be, in my view, a major contributor toward that asset expansion. I think that when we consider our $5 billion target and afterward set that beside where we stand regarding earnings, we're on track in both areas; and I think that's genuinely the persuasive element of the story, which is that we're diversifying a great deal of our revenue, yet we aren't subtracting from the other; and this is truly what I want to drive home here. It's that whenever you examine the Life Solutions business, that Life Solutions business keeps expanding annually. And afterward the asset management business is incremental to it; and so when we contemplate items such as our consensus for year-end, our guidance for year-end, we definitely want to be and believe we'll be at the top end of every one of those numbers, propelled by the reality that we're adding $5 billion potentially — or pardon me, a total target of $5 billion in AUM. But even lacking that, we're still performing rather well in Life Solutions and the remaining portions of our business since for me, it isn't solely about growing ANI and EBITDA, but past that, it's about multiple expansion; and that's genuinely what we're discussing here, which is that people — investors will examine this story and say, "Oh, wow, okay, look at this recurring revenue story driven by additional assets under management, we shouldn't be trading at single-digit or low double-digit multiples. We should be trading closer to our peer group in the mid-teens.
Timothy D'Agostino
analystOkay, great. And then here's another question, on that very slide, about the $3 million tied to technology revenue. Clearly, roughly $0.8 million came in during the first half. I'm just attempting to figure out how that adds up to $3 million. Does LifeARC play any part in that? I'm just trying to piece it together.
Jay Jackson
executiveYeah, LifeARC revenue will be coming in soon, in the near term. This program only launched a month ago. But regarding tech revenue and subscription revenue tied to our mortality verification, the contracts are set up so that revenue rises over time. That means year 2 brings in more than year 1, and then year 3 climbs further, and many of these run for 3 or 5 years. So that revenue should keep climbing, simply based on how the underlying contracts are scheduled. At the start, when a new client comes aboard, you're at a lower cost, and then you move into higher revenue as you reach years 2, 3, 4, and 5. That's how the projection works. So we have, I'd say, embedded revenue forecast within contracts we've already signed. And it doesn't yet necessarily factor in the revenue we expect to see from LifeARC; what's remarkable about LifeARC revenue is that it will be super interesting, since it's also going to assist us in our private wealth channel; so as we grow our assets under management tied to private wealth, LifeARC acts as a driver for that, because it delivers a service and platform that pull people into our private wealth business and generate more recurring revenue.
Randy Binner
analystI've got a few questions here. Regarding the asset management numbers for the quarter, my sense is they fell short of what the Street was anticipating; and based on the rest of what was said during the Q&A, it seems like that's going to bounce back to solid growth. That said, could you elaborate a bit further on what exactly caused the revenue shortfall this quarter? And along those lines, was the fee rate on AUM also somewhat below what was expected for this quarter?
Jay Jackson
executiveYes. My view is that ETFs were the sole driver behind that effect. And there's — an ETF operation on its own is not a high-margin operation. But some money has rotated away from those ETFs, and that's what hurt a portion of the asset management revenue; however, on the Life Solutions — or pardon me, the longevity asset side, that revenue was performing really well. So in any particular quarter, we could witness some rotation in that asset management revenue as we keep growing and moving this toward more fee-related earnings. But nothing stood out — from where we sit, we reviewed it and thought, yes, okay, it's logical that the ETFs experienced some shifts simply in various kinds of assets. And that would have had a minor effect on total asset management revenue; yet when you consider the longer-term revenue relative to this, particularly a few of our private funds and now moving into our interval fund and other products, I believe that squares away extremely, extremely fast and likewise leans more toward steady revenue growth in that area.
Randy Binner
analystAll right. So when we project ahead in the model, the fees tied to assets under management for related parties ought to settle at a somewhat higher level, perhaps above what showed up this quarter?
Jay Jackson
executiveYes, you've got that right.
Randy Binner
analystAll right, that sounds good. Then there's one thing I'd call an administrative detail, though the tax rate came in somewhat elevated during this quarter. That's not beyond the band you'd notice if you look back over several quarters, but did it stand out as atypical? And would it affect in any way what the tax rate might be for the remaining portion of the year?
Bill McCauley
executiveCorrect. Randy, what you'll observe is that it evens out when measured across the full year. Yet for this quarter, I agree, it exceeded what we generally encounter, and a handful of factors caused that, particularly relating to 162M and also the interest deduction; so — however, you'll find it settles back toward our customary rate over the course of the year.
Randy Binner
analystAll right. And Bill, given that it was somewhat elevated in Q1 as well, I believe — so for the entire year, is it roughly 30%? Or does it come in under that?
Bill McCauley
executiveIt ought to be slightly under that.
Dmitrii Primashov
analystI simply wanted to get some clarity when it comes to the dividends. Is it reasonable for us to anticipate that payouts will keep coming at the level they're at now as we move ahead?
Jay Jackson
executiveMy apologies — I missed a portion of what you said. Was your question about the dividends?
Dmitrii Primashov
analystRight. Looking ahead, can we count on the dividend staying where it is right now?
Jay Jackson
executiveCorrect; our dividend is paid once a year. And regarding how we assess those dividend figures — comparing them against fee-related earnings as a percentage, and then against adjusted net income as a percentage — should we follow a comparable approach or comparable math in 2026, that would tell you that, indeed, a higher dividend would be paid for 2026. We don't yet have that final calculated figure. Still, given what we're observing at present, yes, you would see the dividend go up by a percentage this year.
Jay Jackson
executiveThanks again, everybody, and I truly appreciate all of you for being on the call. Our Investor Day went very well; once more, my thanks go out to each person who traveled there. One thing we highlighted is that Abacus is putting our data to work in order to go after what we consider to be among the biggest and most meaningful generational wealth transfers ever witnessed. That figure of $124 trillion, and leveraging our data to capture it — when you look at where we stand now versus where we're headed, I genuinely believe we lead in this particular portion of this generational wealth transfer. As we keep monetizing it, Abacus is developing the capacity to place a commodity and a price on time. Nothing holds greater value than that. We're eager for you to watch how we keep advancing our journey and adding to our whole flywheel. So, thank you, and we look forward to Q3.
Operator
operatorEveryone, that brings today's event to a close. We appreciate your taking part. At this point you're free to disconnect, and enjoy the remainder of your day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Abacus Global Management, Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →This call discussed
For developers and AI pipelines
Programmatic access to Abacus Global Management, Inc. earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Abacus Global Management, Inc. or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.